Related Experiment Video
Updated: Jan 25, 2026

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
Published on: February 21, 2025
Computed tomographic coronary angiography in risk stratification prior to non-cardiac surgery: a systematic review
Anoop N Koshy1,2,3, Francis Jonathan Ha1, Paul J Gow2,3
1Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
Insights
CT coronary angiography (CTA) and coronary artery calcium (CAC) scoring can effectively stratify risk for major adverse cardiovascular events (MACE) before non-cardiac surgery. CTA's ability to rule out coronary artery disease (CAD) is valuable for preoperative risk assessment.
Area of Science:
- Cardiology
- Radiology
- Perioperative Medicine
Background:
- Current guidelines recommend stress testing for intermediate-high risk individuals before non-cardiac surgery.
- Over one-third of perioperative major adverse cardiovascular events (MACE) occur in patients with negative stress tests.
- The utility of CT coronary angiography (CTA) and coronary artery calcium (CAC) scoring for preoperative risk stratification remains unclear.
Purpose of the Study:
- To evaluate the value of CTA and CAC score in preoperative risk prognostication prior to non-cardiac surgery.
- To assess the association between coronary artery disease (CAD) severity and extent on CTA and perioperative MACE.
- To determine the predictive value of CAC scoring for perioperative MACE.
Main Methods:
- A systematic review and meta-analysis of studies published up to June 2018.
- MEDLINE, PubMed, and EMBASE databases were searched.
- Random-effects model was used to pool summary odds ratios (ORs) for degree of CAD and perioperative MACE.
Main Results:
- Eleven studies involving 3480 patients were included, with 252 (7.2%) MACE.
- Risk of MACE increased with CAD severity on CTA: no CAD (2.0%), non-obstructive (4.1%), single-vessel (7.1%), and multivessel disease (MVD) (23.1%).
- Increasing CAC scores (≥100 and ≥1000) were associated with higher perioperative MACE (OR 5.1 and 10.4, respectively). Absence of MVD on CTA had a 96% negative predictive value for freedom from MACE in high-risk patients.
Conclusions:
- Severity and extent of CAD on CTA confer incremental risk for perioperative MACE in patients undergoing non-cardiac surgery.
- CTA demonstrates a 'rule-out' capability comparable to other non-invasive imaging modalities.
- CTA offers a viable alternative for risk stratification in patients undergoing non-cardiac surgery.
Objectives:
Utility of CT coronary angiography (CTA) and coronary artery calcium (CAC) scoring in risk stratification prior to non-cardiac surgery is unclear. Although current guidelines recommend stress testing in intermediate-high risk individuals, over one-third of perioperative major adverse cardiovascular events (MACE) occur in patients with a negative study. This systematic review and meta-analysis evaluates the value of CTA and CAC score in preoperative risk prognostication prior to non-cardiac surgery.
Methods:
MEDLINE, PubMed and EMBASE databases were searched for articles published up to June 2018. Summary ORs for degree of coronary artery disease (CAD) and perioperative MACE were pooled using a random-effects model.
Results:
Eleven studies were included. Two hundred and fifty-two (7.2%) MACE occurred in 3480 patients. Risk of perioperative MACE rose with the severity and extent of CAD on CTA (no CAD 2.0%; non-obstructive 4.1%; obstructive single-vessel 7.1%; obstructive multivessel 23.1%, p<0.001). Multivessel disease (MVD) demonstrated the greatest risk (OR 8.9, 95% CI 5.1 to 15.3, p<0.001). Increasing CAC score was associated with higher perioperative MACE (CAC score: ≥100 OR 5.1, ≥1000 OR 10.4, both p<0.01). In a cohort deemed high risk by established clinical indices, absence of MVD on CTA demonstrated a negative predictive value of 96% (95% CI 92.8 to 98.4) for predicting freedom from MACE.
Conclusions:
Severity and extent of CAD on CTA conferred incremental risk for perioperative MACE in patients undergoing non-cardiac surgery. The 'rule-out' capability of CTA is comparable to other non-invasive imaging modalities and offers a viable alternative for risk stratification of patients undergoing non-cardiac surgery.
Trial Registration Number:
CRD42018100883.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Relative Risk

